Results 131 to 140 of about 5,912,858 (156)

Screening for carcinoid heart disease: Trends and future Perspectives. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Mouser B, Howe JR, Atari O, Dillon JS, Chandrasekharan C, Parekh KR, Bashir MA.   +6 more
europepmc   +1 more source

A survey of UK-based screening and surveillance practices for carcinoid heart disease in patients with neuroendocrine tumours. [PDF]

Endocr Oncol
Douglas S, Shah T, Steeds RP, Dobson R.
europepmc   +1 more source

Doença cardíaca carcinoide Carcinoid heart disease

Arquivos Brasileiros de Cardiologia, 2013
Sameer Chadha, Ankur Lodha, Vijay Shetty, Adnan Sadiq, Gerald Hollander, Jacob Shani   +5 more
doaj  

Does Telotristat Have a Role in Preventing Carcinoid Heart Disease? [PDF]

Int J Mol Sci
Herrera-Martínez AD, Fuentes-Fayos AC, Sanchez-Sanchez R, Montero AJ, Sarmento-Cabral A, Gálvez-Moreno MA, Gahete MD, Luque RM.   +7 more
europepmc   +1 more source

Late-onset multivalvular carcinoid heart disease. [PDF]

Arch Cardiol Mex
Rivera K, Zielonka M, Ramírez-Martínez T, Pueyo-Balsells N, Fernández-Rodríguez D.   +4 more
europepmc   +1 more source

Cardiac Imaging in Carcinoid Heart Disease.

JACC: Cardiovascular Imaging, 2021
Carcinoid disease is caused by neuroendocrine tumors, most often located in the gut, and leads in approximately 20% of cases to specific, severe heart disease, most prominently affecting right-sided valves.
Jens Sörensen, Anders Albåge
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)

Journal of Neuroendocrinology, 2022
Andrea Frilling, Angela Lamarca
exaly  

Progression of Carcinoid Heart Disease in the Modern Management Era

Journal of the American Heart Association, 2021
Céline LEPERE, Nicolas Mansencal, Hélène Hergault   +2 more
exaly  

Carcinoid Heart Disease

Circulation, 2007
Sanjeev Bhattacharyya, Gilles Dreyfus, Joseph Davar   +2 more
exaly